Researcher Next
Create account
← Back to directory

Lars Køber

Researcher Next ID · RN-021315

Researcher · Medicine

University of Copenhagen

Copenhagen, Denmark

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
2,125
Citation count
149,002
H-index
156
i10-index
1,089

Research interests

Medicine
Heart Failure Treatment and Management
Cardiovascular Function and Risk Factors
Acute Myocardial Infarction Research
Atrial Fibrillation Management and Outcomes
Cardiac Imaging and Diagnostics

Publications

  • 2025 ESC/EACTS Guidelines for the management of valvular heart disease

    European Heart Journal · 2025 · https://doi.org/10.1093/eurheartj/ehaf194

  • 2024 ESC Guidelines for the management of chronic coronary syndromes

    European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae177

  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae176

  • 2024 ESC Guidelines for the management of elevated blood pressure and hypertension

    European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae178

  • 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

    European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae179

  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal · 2023 · 10.1093/eurheartj/ehad195

  • 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

    European Heart Journal · 2023 · 10.1093/eurheartj/ehad192

  • 2023 ESC Guidelines for the management of endocarditis

    European Heart Journal · 2023 · 10.1093/eurheartj/ehad193

  • Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

    Nature Communications · 2020 · 10.1038/s41467-019-13690-5

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    The Lancet Diabetes & Endocrinology · 2019 · 10.1016/s2213-8587(19)30249-9

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1911303

  • Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1608029

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    New England Journal of Medicine · 2015 · 10.1056/nejmoa1509225

  • Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic Shock

    European Journal of Heart Failure · 2015 · 10.1002/ejhf.260

  • Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

    JAMA · 2013 · 10.1001/jama.2013.278483

  • Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

    New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1310519

  • Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE

    European Journal of Heart Failure · 2012 · 10.1093/eurjhf/hfs033

  • ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012

    European Journal of Heart Failure · 2012 · 10.1093/eurjhf/hfs105

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs104

  • Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

    European Heart Journal · 2012 · 10.1093/eurheartj/ehs337

  • Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0800456

  • Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

    New England Journal of Medicine · 2005 · 10.1056/nejmoa043938

  • Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

    New England Journal of Medicine · 2004 · 10.1056/nejmoa041365

  • Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

    Circulation · 2004 · 10.1161/01.cir.0000124490.27666.b2

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    New England Journal of Medicine · 2003 · 10.1056/nejmoa032292

  • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

    The Lancet · 2000 · 10.1016/s0140-6736(00)02212-1

  • Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

    New England Journal of Medicine · 1999 · 10.1056/nejm199909163411201

  • A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

    New England Journal of Medicine · 1995 · 10.1056/nejm199512213332503

Current projects

    No projects listed.